ArticleJournal of the American Geriatrics Society2025
Life-Prolonging Treatment Preferences and Their Association With Health Care Utilization and End-Of-Life Experiences in Older Adults.
Article in Journal of the American Geriatrics Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Life-Prolonging Treatment Preferences and Their Association With Health Care Utilization and End-Of-Life Experiences in Older Adults.Journal of the American Geriatrics Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPeople markedly differ in their preferences for life-prolonging treatments (LPT). We explored the association between LPT preferences and healthcare utilization and end-of-life (EOL) experiences.
methodsWe conducted a retrospective cohort study using data from 5373 older adults in the National Health and Aging Trends Study (NHATS) linked to Medicare/Medicaid. Among them, 1564 died, and 1124 had proxies who completed the Last Month of Life module. We categorized LPT preferences (accept or reject) in severe disability or pain scenarios, and we assessed healthcare utilization (hospitalization, ICU visits, receipt of LPT, hospice), total cost, and days out of home in the last year of life, place of death, and EOL experiences.
resultsThe average age of respondents was 76.7 years (SD 5.9), 55.1% female, and 7.8% Black people. Sixty-nine percent would reject all LPT; 5.3% would accept LPT only in the severe disability scenario; 15.8% would accept LPT only in the pain scenario; and 9.9% in both. There was no association between LPT preferences and hospitalization, ICU visits, receipt of LPT, or costs. Respondents accepting LPT for pain spent more time away from home (3.4 days, 95% CI: 0.3, 6.6, p = 0.03). Among decedents, preferences were not linked to receipt of LPT, hospice use, or EOL care quality. Those accepting LPT for severe disability and pain had higher odds of dying in a hospital (OR = 1.8, 95% CI 1.1-3, p < 0.03) compared to those who would reject LPT.
conclusionsLPT preferences established in hypothetical scenarios were not associated with health care utilization, cost, or perceived quality of end-of-life. As LPT preferences should influence care, subsequent work, such as understanding preference measurement, real-world preference changes, or the limited opportunity for preferences to influence care, is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.